1.
Multitargeted therapy of cancer by green tea polyphenols
by Khan, Naghma
Cancer letters, 2008, Vol.269 (2), p.269-280
2.
Bakuchiol attenuates myocardial ischemia reperfusion injury by maintaining mitochondrial function: the role of silent information regulator 1
by Feng, Jianyu
Apoptosis (London), 2016-03-21, Vol.21 (5), p.532-545
3.
Protective effects of propolis and related polyphenolic/flavonoid compounds against toxicity induced by irinotecan
by Oršolić, Nada
Medical oncology (Northwood, London, England), 2009-12-16, Vol.27 (4), p.1346-1358
4.
Green tea polyphenol suppresses tumor invasion and angiogenesis in N-butyl-(-4-hydroxybutyl) nitrosamine-induced bladder cancer
by Sagara, Yuji
Cancer epidemiology, 2010, Vol.34 (3), p.350-354
5.
Recently identified and potential targets for colon cancer treatment
by Lea, Michael A
Future oncology (London, England), 2010-06-01, Vol.6 (6), p.993-1002
6.
Effects of cacao liquor proanthocyanidins on PhIP-induced mutagenesis in vitro, and in vivo mammary and pancreatic tumorigenesis in female Sprague–Dawley rats
by Yamagishi, Megumi
Cancer letters, 2002, Vol.185 (2), p.123-130
7.
Inhibition of TPA-induced tumor promotion in CD-1 mouse epidermis by a polyphenolic fraction from grape seeds
by Bomser, J.A
Cancer letters, 1999, Vol.135 (2), p.151-157
8.
Development of a rat model by 3,4-benzopyrene intra-pulmonary injection and evaluation of the effect of green tea drinking on p53 and bcl-2 expression in lung carcinoma
by Gu, Qihua
Cancer detection and prevention, 2009, Vol.32 (5), p.444-451
9.
Green Tea Polyphenols and Cancer Chemoprevention: Multiple Mechanisms and Endpoints for Phase II Trials
by Moyers, Susan B
Nutrition reviews, 2004-05, Vol.62 (5), p.204-211
10.
Tea chemicals confirmed as cancer-busting compounds
by Morris, Kelly
The lancet oncology, 2002, Vol.3 (5), p.262-262
11.
Protective effects of green tea polyphenols administered by oral intubation against chemical carcinogen-induced forestomach and pulmonary neoplasia in A/J mice
by Katiyar, Santosh K
Cancer letters, 1993, Vol.73 (2), p.167-172
12.
Spleen peptides (PolyergaTM) inhibit development of artificial lung metastases of murine mammary carcinoma and increase efficiency of chemotherapy in mice
by ZARKOVIC, N
Cancer biotherapy & radiopharmaceuticals, 1998, Vol.13 (1), p.25-32
13.
Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
by Roviello, Giandomenico
Cancer letters, 2016, Vol.372 (2), p.187-191
14.
Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer
by Tan, Chee-Seng
Lung cancer (Amsterdam, Netherlands), 2016, Vol.93, p.59-68
15.
Accelerated lipid catabolism and autophagy are cancer survival mechanisms under inhibited glutaminolysis
by Halama, Anna
Cancer letters, 2018-08-28, Vol.430, p.133-147
16.
Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer
by Tong, Christy W.S
Cancer letters, 2017-10-01, Vol.405, p.100-110
17.
Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer
by Yamaguchi, Norihiro
Lung cancer (Amsterdam, Netherlands), 2013, Vol.83 (1), p.37-43
18.
Efficacy of epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in non-small cell lung cancer patients harboring either exon 19 or 21 mutation
by Park, S.J
Lung cancer (Amsterdam, Netherlands), 2012, Vol.77 (3), p.556-560
19.
Estrogen receptor beta as target for colorectal cancer prevention
by Williams, Cecilia
Cancer letters, 2015, Vol.372 (1), p.48-56
20.
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer
by Araki, Kazuhiro
Breast cancer (Tokyo, Japan), 2017-10-31, Vol.25 (4), p.392-401
Filter electronic articles 101 Hits
Remove Filters
- Subjects
- Oncology
- Science & Technology (99)
- Life Sciences & Biomedicine (99)
- more ...